{"id":"NCT00624052","sponsor":"Boehringer Ingelheim","briefTitle":"26-week Open Study of telmisartan40mg+amlodipine10mg or telmisartan80mg+amlodipine10 mg in Hypertension","officialTitle":"An Open Label Trial of the Efficacy and Safety of Chronic Administration of the Fixed Dose Combination of Telmisartan 40mg + Amlodipine 10mg or Fixed Dose Combination of Telmisartan 80mg + Amlodipine 10mg Tablets Alone or in Combination With Other Antihypertensive Medications in Patients With Hypertension","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-03","primaryCompletion":"2009-06","completion":null,"firstPosted":"2008-02-26","resultsPosted":"2010-03-25","lastUpdate":"2014-05-20"},"enrollment":838,"design":{"allocation":null,"model":null,"masking":null,"primaryPurpose":"TREATMENT"},"conditions":["Hypertension"],"interventions":[{"type":"DRUG","name":"fixed-dose combination of telmisartan 40mg+amlodipine 10mg","otherNames":[]},{"type":"DRUG","name":"fixed-dose combination of telmisartan 80mg+amlodipine10mg","otherNames":[]}],"arms":[],"summary":"The primary objective of this trial is to assess the efficacy and safety of the fixed dose combinations telmisartan 40mg/amlodipine 10mg (T40/A10) or telmisartan 80mg/amlodipine 10mg (T80/A10) during open-label treatment for at least six months.\n\nAn additional objective is to assess the efficacy and safety of concomitant administration of either T40/A10 or T80/A10 with any other therapies commonly used in the treatment of hypertension.\n\nThe primary endpoint is the proportion of patients achieving DBP control (defined as mean seated DBP \\< 90 mmHg at trough i.e. approximately 24 hours after last dose of study treatment) at six months of treatment or at last trough observation during the treatment period (i.e. last trough observation carried forward).","primaryOutcome":{"measure":"Trough Seated Diastolic Blood Pressure (DBP) Control","timeFrame":"End of study (34 weeks or last value on treatment)","effectByArm":[{"arm":"Telmisartan 40mg and Amlodipine 10mg","deltaMin":201,"sd":null},{"arm":"Randomised Telmisartan 80mg and Amlodipine 10mg","deltaMin":402,"sd":null},{"arm":"Titrated Telmisartan 80mg and Amlodipine 10mg","deltaMin":72,"sd":null},{"arm":"Telmisartan 40mg or 80mg and Amlodipine 10mg + add-on","deltaMin":70,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG002","p":null},{"comp":"OG000 vs OG003","p":null},{"comp":"OG001 vs OG002","p":null},{"comp":"OG001 vs OG003","p":null},{"comp":"OG002 vs OG003","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":17},"locations":{"siteCount":92,"countries":["Australia","Austria","Bulgaria","Czechia","Ireland","Italy","New Zealand","Russia","Slovakia","Spain","Ukraine","United Kingdom"]},"refs":{"pmids":["24653513"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":838},"commonTop":[]}}